These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38255857)

  • 1. Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study.
    Ammendola S; Romeo S; Cattazzo F; Mantovani A; Ieluzzi D; Paon V; Montagnana M; Pecori S; Tomezzoli A; Dalbeni A; Sacerdoti D
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed cryoglobulinemia and hepatitis C virus.
    Cacoub P; Fabiani FL; Musset L; Perrin M; Frangeul L; Leger JM; Huraux JM; Piette JC; Godeau P
    Am J Med; 1994 Feb; 96(2):124-32. PubMed ID: 7509124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
    Gragnani L; Piluso A; Urraro T; Fabbrizzi A; Fognani E; Petraccia L; Genovesi A; Giubilei L; Ranieri J; Stasi C; Monti M; Zignego AL
    Curr Drug Targets; 2017; 18(7):772-785. PubMed ID: 26853322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy.
    Mazzaro C; Dal Maso L; Mauro E; Visentini M; Tonizzo M; Gattei V; Andreone P; Pozzato G
    Autoimmun Rev; 2020 Aug; 19(8):102589. PubMed ID: 32540448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryoglobulinemia after the era of chronic hepatitis C infection.
    Boleto G; Ghillani-Dalbin P; Musset L; Biard L; Mulier G; Cacoub P; Saadoun D
    Semin Arthritis Rheum; 2020 Aug; 50(4):695-700. PubMed ID: 32521323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
    Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
    Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
    Gragnani L; Fognani E; Piluso A; Boldrini B; Urraro T; Fabbrizzi A; Stasi C; Ranieri J; Monti M; Arena U; Iannacone C; Laffi G; Zignego AL;
    Hepatology; 2015 Apr; 61(4):1145-53. PubMed ID: 25431357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
    Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
    Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Guillain-Barré syndrome associated with chronic active hepatitis C and mixed cryoglobulinemia: a case report.
    Chlilek A; Roger C; Muller L; Carles MJ; Stephan R; Laureillard D; Lavigne JP; Lefrant JY; Sotto A
    BMC Infect Dis; 2019 Jul; 19(1):636. PubMed ID: 31315560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
    Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
    Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
    Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
    Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
    J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Saadoun D; Limal N; Sene D; Lidove O; Piette JC
    Arthritis Rheum; 2005 Mar; 52(3):911-5. PubMed ID: 15751068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Mixed Cryoglobulinemia Despite Sustained Virologic Response to Treatment: A Case Report.
    Chowdhury R; Tsen A
    Am J Kidney Dis; 2017 Aug; 70(2):301-304. PubMed ID: 28343737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.
    Levine JW; Gota C; Fessler BJ; Calabrese LH; Cooper SM
    J Rheumatol; 2005 Jun; 32(6):1164-7. PubMed ID: 15940780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
    Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
    Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
    Basile U; Gragnani L; Piluso A; Gulli F; Urraro T; Dell'Abate MT; Torti E; Stasi C; Monti M; Rapaccini GL; Zignego AL
    Liver Int; 2015 Sep; 35(9):2100-7. PubMed ID: 25800731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.